Literature DB >> 8004757

In vivo modulation of several anticancer agents by beta-carotene.

B A Teicher1, J L Schwartz, S A Holden, G Ara, D Northey.   

Abstract

The ability of the collagenase inhibitor minocycline and of beta-carotene to act as positive modulators of cytotoxic anticancer agents was assessed in vitro and in vivo. Cell-culture studies were conducted using the human SCC-25 squamous carcinoma cell line. Simultaneous exposure of the cells to minocycline and beta-carotene or 13-cis-retinoic acid along with cisplatin (CDDP) resulted in a small decrease in the cytotoxicity of the CDDP. The addition of each of the modulator combinations for 1 h or 24 h to treatment with melphalan (L-PAM) or carmustine (BCNU) resulted in greater-than-additive cytotoxicity with each of four regimens. The modulator combinations of minocycline and beta-carotene applied for 1 h or 24 h and the modulator combination of minocycline and 13-cis-retinoic acid produced greater-than-additive cytotoxicity at 50 microM 4-hydroperoxycyclophosphamide (4-HC), whereas minocycline and 13-cis-retinoic acid applied for 1 h was antagonistic with 4-HC and the other modulator treatments at low concentrations of 4-HC resulted in subadditive cytotoxicity. The effect of treatment with beta-carotene alone and in combination with several different anticancer agents was examined in two murine solid tumors, the FSaII fibrosarcoma and the SCC VII carcinoma. Administration of the modulators alone or in combination did not alter the growth of either tumor. Whereas increases in tumor growth delay occurred with the antitumor alkylating agents and beta-carotene and with minocycline and beta-carotene, a diminution in tumor growth delay was produced by 5-fluorouracil in the presence of these modulators. The modulator combination also resulted in increased tumor growth delay with adriamycin and etoposide. Tumor-cell survival assay showed increased killing of FSaII tumor cells with the modulator combination and melphalan or cyclophosphamide as compared with the drugs alone. These results indicate that further investigation of this modulator strategy is warranted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004757     DOI: 10.1007/BF00685083

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  70 in total

1.  Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities.

Authors:  A F Stewart; R E Herrera; A Nordheim
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

2.  Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

Authors:  C W White; H M Sondheimer; E C Crouch; H Wilson; L L Fan
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.

Authors:  S M Lippman; J J Kavanagh; M Paredes-Espinoza; F Delgadillo-Madrueño; P Paredes-Casillas; W K Hong; G Massimini; E E Holdener; I H Krakoff
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

5.  Tetracyclines inhibit human synovial collagenase in vivo and in vitro.

Authors:  R A Greenwald; L M Golub; B Lavietes; N S Ramamurthy; B Gruber; R S Laskin; T F McNamara
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

6.  Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells.

Authors:  R J Rotello; R C Lieberman; A F Purchio; L E Gerschenson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

7.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors:  W K Hong; S M Lippman; L M Itri; D D Karp; J S Lee; R M Byers; S P Schantz; A M Kramer; R Lotan; L J Peters
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

8.  Regression of experimental cancer by oral administration of combined alpha-tocopherol and beta-carotene.

Authors:  G Shklar; J Schwartz; D Trickler; S Reid
Journal:  Nutr Cancer       Date:  1989       Impact factor: 2.900

9.  Inhibition of angiogenesis through modulation of collagen metabolism.

Authors:  D Ingber; J Folkman
Journal:  Lab Invest       Date:  1988-07       Impact factor: 5.662

10.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

View more
  8 in total

Review 1.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

2.  Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes.

Authors:  R Matsushima-Nishiwaki; Y Shidoji; S Nishiwaki; T Yamada; H Moriwaki; Y Muto
Journal:  Lipids       Date:  1995-11       Impact factor: 1.880

3.  Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysis.

Authors:  Shenghui Wu; Yanning Liu; Joel E Michalek; Ruben A Mesa; Dorothy Long Parma; Ronald Rodriguez; Ahmed M Mansour; Robert Svatek; Thomas C Tucker; Amelie G Ramirez
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

Review 4.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

5.  Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation.

Authors:  Marie H Hanigan; Brian L Dela Cruz; David M Thompson; Kevin C Farmer; Patrick J Medina
Journal:  J Oncol Pharm Pract       Date:  2008-09       Impact factor: 1.809

6.  Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cells.

Authors:  Murat Pekmez; Evren Önay-Uçar; Nazli Arda
Journal:  Exp Ther Med       Date:  2014-12-03       Impact factor: 2.447

Review 7.  Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - Exploring the armoury of obscurity.

Authors:  Kanchanlata Singh; Mustansir Bhori; Yasar Arfat Kasu; Ganapathi Bhat; Thankamani Marar
Journal:  Saudi Pharm J       Date:  2017-12-19       Impact factor: 4.330

8.  Antioxidant Antagonises Chemotherapeutic Drug Effect in Lung Cancer Cell Line A549.

Authors:  Swetha Rajendran; Aishwarya Lakshminarayanan; Gnanasambandan Ramanathan; Suresh Kannan Subramanian Shanmugam
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.